Latest cardioversion Stories
NASDAQ: CRME TSX: COM VANCOUVER, Nov. 7, 2014 /PRNewswire/ - Cardiome Pharma Corp.
Defendant Xarelto manufacturers want several lawsuits dismissed from Pennsylvania state court, arguing that there is no connection with the state. Rockville
The results of a recently-concluded study purport to show that Xarelto (rivaroxaban) is as safe as warfarin for patients atrial fibrillation patients awaiting elective cardioversion, even though
Transparency Market Research published the new report "Atrial Fibrillation Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report store.
NASDAQ: CRME TSX: COM VANCOUVER, Feb. 13, 2014 /PRNewswire/ - Cardiome Pharma Corp.
- A poem in which the author retracts something said in an earlier poem.